Loading clinical trials...
Loading clinical trials...
Effectiveness and Safety of PERIoperative Factor Xa Inhibitor Discontinuation in Patients with Atrial Fibrillation Who Undergoing Minor Bleeding Risk Elective Procedure or Surgery: a Prospective, Multicenter, Noninterventional Study (PERIXa Study)
Conditions
Interventions
Factor Xa Inhibitor
Locations
1
South Korea
Seoul National university Hostpital
Seoul, Jongno-gu, South Korea
Start Date
August 4, 2020
Primary Completion Date
May 15, 2024
Completion Date
December 31, 2025
Last Updated
January 7, 2025
NCT05147792
NCT06935591
NCT05963698
NCT03546374
NCT04947657
NCT06686485
Lead Sponsor
Seoul National University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions